Laboratory Testing - what we need and what we don't?

被引:9
|
作者
Moeckel, Martin [1 ,2 ,3 ]
Mueller, Christian [4 ,5 ]
Lindner, Tobias [6 ,7 ]
Searle, Julia [7 ,8 ]
机构
[1] Campus Virchow Klinikums, Arbeitsbereichs Notfallmed Rettungsstellen Aufnah, Berlin, Germany
[2] Campus Virchow Klinikums, Chest Pain Units, Berlin, Germany
[3] Campus Charite Mitte, Berlin, Germany
[4] Charite, Zent Lab, Berlin, Germany
[5] Charite, Forsch Grp Arbeitsbereiches Notfallmed, Berlin, Germany
[6] Charite, Chirurg & Unfallchirurg Orthopadie Klin Notfall &, Berlin, Germany
[7] Charite, Arbeitsbereiches Notfallmed, Berlin, Germany
[8] Charite, Bereich Forsch, Berlin, Germany
关键词
EMERGENCY-DEPARTMENT; PROCALCITONIN; DIAGNOSIS; GUIDELINES; MANAGEMENT; OUTCOMES; SOCIETY; SEPSIS; IDENTIFICATION; DISORDERS;
D O I
10.1055/s-0041-109207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laboratory parameters in emergency medicine can be divided into 3 categories. Urgent obligatory parameters are necessary for immediate therapeutic decisions and must be available within 60 minutes. For these, testing in the emergency department (ED) as point-of-care-testing (POCT) should be considered. The second category are obligatory parameters which require diagnostic/therapeutic consequences in the emergency department, but are not necessary for immediate life-saving actions. Due to international consensus of a 4-hour length of stay target for ED, results should be available within this time. The third category are parameters which do not lead to immediate diagnostic or therapeutic consequences, but are important for process management and patient flow in the ED. They should therefore be available as emergency tests. POC-testing should be used for a limited number of very urgent parameters and should be organized as a satellite laboratory in cooperation with the central laboratory.
引用
收藏
页码:322 / +
页数:9
相关论文
共 50 条
  • [41] What we (don't) know about what we know
    Sher, Shlomi
    Winkielman, Piotr
    BEHAVIORAL AND BRAIN SCIENCES, 2014, 37 (01) : 38 - 39
  • [42] The Economics of Entrepreneurship: What We Know and What We Don't
    Parker, Simon C.
    FOUNDATIONS AND TRENDS IN ENTREPRENEURSHIP, 2005, 1 (01): : 1 - 53
  • [43] Exiting the ER: what we know and what we don't
    Venditti, Rossella
    Wilson, Cathal
    De Matteis, Maria Antonietta
    TRENDS IN CELL BIOLOGY, 2014, 24 (01) : 9 - 18
  • [44] Prebiotic Chemistry: What We Know, What We Don't
    H. James Cleaves
    Evolution: Education and Outreach, 2012, 5 (3) : 342 - 360
  • [45] The power of swearing: What we know and what we don't
    Stapleton, Karyn
    Fagersten, Kristy Beers
    Stephens, Richard
    Loveday, Catherine
    LINGUA, 2022, 277
  • [46] Familial hematurias: what we know and what we don’t
    Clifford E. Kashtan
    Pediatric Nephrology, 2005, 20 : 1027 - 1035
  • [47] Ductal lavage: What we know and what we don't
    Newman, Lisa A.
    ONCOLOGY-NEW YORK, 2004, 18 (02): : 179 - 185
  • [48] We don't know what we need to know about atrial fibrillation
    McCarthy, Patrick M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (04): : 1522 - 1523
  • [49] Overcoming Inequities in Obesity: What Don't We Know That We Need to Know?
    Kumanyika, Shiriki
    HEALTH EDUCATION & BEHAVIOR, 2019, 46 (05) : 721 - 727
  • [50] Apheresis turnaround: Where we are, where we need to be, what happens if we fix it if we don't
    Mascolino, J
    TRANSFUSION, 2003, 43 (09) : 155A - 155A